# FDA Inspection 1102899 - Sangamo Therapeutics, Inc - July 11, 2019

Source: https://www.keypedia.com/records/fda_inspections/sangamo-therapeutics-inc/b2bcde8d-36b0-42c0-a643-284b3f1ad52c
Source feed: FDA_Inspections

> FDA Inspection 1102899 for Sangamo Therapeutics, Inc on July 11, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1102899
- Company Name: Sangamo Therapeutics, Inc
- Inspection Date: 2019-07-11
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 711115 - 2011-03-07](https://www.keypedia.com/records/fda_inspections/sangamo-therapeutics-inc/7cb95f55-3b0a-4daf-be12-2954e0243f78)

Company: https://www.keypedia.com/companies/sangamo-therapeutics-inc/9452e68e-8f35-4c52-8fa2-2d7862895727

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d